Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

Published:2016-11-01 Issue:11 Volume:2 Page:1441
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Scher Howard I.¹,Lu David²,Schreiber Nicole A.³,Louw Jessica²,Graf Ryon P.²,Vargas Hebert A.⁴,Johnson Ann²,Jendrisak Adam²,Bambury Richard⁵,Danila Daniel¹,McLaughlin Brigit³,Wahl Justin²,Greene Stephanie B.²,Heller Glenn⁶,Marrinucci Dena²,Fleisher Martin⁷,Dittamore Ryan²

Affiliation:

1. Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Medicine, Weill Cornell Medical College, New York, New York

2. Epic Sciences, La Jolla, California

3. Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

4. Body Imaging Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York

5. Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York6Cancer Services, Department of Medical Oncology, Cork University Hospital, Wilton, Cork, Ireland

6. Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

7. Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 507 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The yin and yang of chromosomal instability in prostate cancer;Nature Reviews Urology;2024-02-02

2. Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance;Critical Reviews in Oncology/Hematology;2024-02

3. Increased chromatin accessibility drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancer;2024-01-12

4. Exploiting the DNA Damage Response for Prostate Cancer Therapy;Cancers;2023-12-23

5. Rational optimization of a transcription factor activation domain inhibitor;Nature Structural & Molecular Biology;2023-12